Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Bipartisan DXA Bill Under Consideration in Congress

From the College  |  June 21, 2021

The Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act would set a $98 floor for Medicare reimbursement for the dual-energy X-ray absorptiometry (DXA) bone density test.

Filed under:Billing/CodingLegislation & Advocacy Tagged with:dual-energy X-ray absorptiometry (DXA)Legislation & AdvocacyMedicare reimbursement rate

Higher Risk of Adverse Events When Biologic Infusions Are Done at Home

By Lisa Rapaport  |  June 15, 2021

(Reuters Health)—Patients who receive biologic infusions at home may have a higher risk of adverse events than those who receive the infusions at a health care facility, a new study suggests.1 Researchers examined administrative claims data on 57,220 adults who received a total of 752,150 biologic infusions for immune-mediated disease between 2007 and 2017. The…

Filed under:Biologics/DMARDsDrug Updates Tagged with:biologic infusionsBiologicshome infusion

Rheum After 5: Dr. Eric Schned Shares Memories of Woodstock

Carol Patton  |  June 14, 2021

When Eric S. Schned, MD, was 19 years old, he spotted a tiny ad in his local newspaper for a concert. As days and weeks passed, the ad grew bigger as bands were added to the lineup. He, his twin brother and two friends decided the concert “looked really cool” and purchased tickets. That may…

Filed under:Rheum After 5 Tagged with:Dr. Eric Schned

Case Report: Child Develops Coronary Artery Aneurysms with GPA

Tryphina Adel Mikhail & Mary Bratovich Toth, MD  |  June 14, 2021

In September 2019, a previously healthy, 9-year-old white girl presented to the emergency department following two months of sinusitis and unexplained fever responsive to ibuprofen. She presented with anorexia; a 9 lb. weight loss; intermittent, nonbilious, nonbloody emesis; and occasional epistaxis with digital manipulation of the nose. Six weeks prior to admission, she had presented to…

Filed under:ConditionsPediatric ConditionsVasculitis Tagged with:case reportcoronary artery anuerysmsgranulomatosis with polyangiitisPediatricPediatric Rheum

TrifonenkoIvan / shutterstock.com

Artificial Intelligence Gives Rheumatologists an Assist

Mary Beth Nierengarten  |  June 14, 2021

As the novel coronavirus that causes COVID-19 spreads across the globe, innovative thinking is needed more than ever to counter the devastating effects on the physical and socioeconomic health of individuals and communities. Innovations in healthcare delivery not yet fully realized prior to the pandemic, such as the adoption of telehealth, are moving to the…

Filed under:ConditionsInformation TechnologyTechnology Tagged with:artificial intelligencebig dataimagingmachine learningTechnology

Case Report: Does a Young Woman with Gitelman Syndrome Have Gout?

Rebecca Lindsey Weiner, DO, & Ann K. Rosenthal, MD, FACP  |  June 14, 2021

Gout is the most common type of inflammatory arthritis in adults, and it typically occurs in men over the age of 50. When gout presents in younger patients or in women, this should warrant consideration of secondary causes. We describe an unusual genetic cause of tophaceous gout in a young, premenopausal woman. Case Report In…

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:case reportGitelman SyndromeGout

Studies Probe Treating Rheumatoid Arthritis with Vagus Nerve Stimulation

Jason Liebowitz, MD, FACR  |  June 14, 2021

When rheumatologists think about rheumatoid arthritis (RA), they are apt to picture the synovium, contemplate such antibodies as rheumatoid factor and those to citrullinated proteins, and consider how this interplay of factors manifests in disease. What is not as commonly discussed is the role the autonomic nervous system plays in the pathogenesis and symptomatology of…

Filed under:ConditionsRheumatoid Arthritis Tagged with:vagus nerve stimulation

A Unified Advocacy Voice for Rheumatology

David R. Karp, MD, PhD, & Christine Stamatos, DNP, ANP-C  |  June 13, 2021

One thing that became clear very quickly this past year was that the COVID-19 pandemic would change the way we deliver care to patients. What has not changed amid an evolving healthcare landscape is our driving focus to ensure our patients’ access to rheumatology care and the availability of state-of-the-art treatments. We know you share…

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:COVID-19RheumPACSafe Step Act

Cohort Study Reveals Patients Treated with Rituximab Have Poorer COVID-19 Outcomes

Lara C. Pullen, PhD  |  June 7, 2021

According to a recent cohort study, patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab therapy experience more severe COVID-19. Researchers also found an association between rituximab use and prolonged hospital stays.

Filed under:Conditions Tagged with:COVID-19Outcomesrituximab

COVID-19 Outcomes in Patients with Rheumatic Disease

Arthritis & Rheumatology  |  June 1, 2021

In a study of patients with systemic autoimmune rheumatic diseases (ARDs) and matched comparators with COVID-19 but without systemic ARDs, D’Silva et al. found COVID-19 patients with systemic ARDs may be at a higher risk of hospitalization, ICU admission and more than matched comparators.

Filed under:ConditionsResearch Rheum Tagged with:Arthritis & RheumatologyAutoimmune diseaseCOVID-19OutcomesResearch

  • « Previous Page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences